Temporal_association_of_CD40_antigen_expression_with_discrete_stages_of_human_B-cell_ontogeny_and_the_efficacy_of_anti-CD40_immunotoxins_against_clonogenic_B-lineage_acute_lymphoblastic_leukemia_as_well_as_B-lineage_non-Hodgkin's_lymphoma_cells._Detailed_immunophenotypic_analyses_of_immunologically_classified_leukemias_and_lymphomas_showed_that_CD40_displays_an_exquisite_B-lineage_specificity_within_the_human_lymphopoietic_system._Notably,_82%_of_B-lineage_chronic_lymphocytic_leukemias_(CLLs),_82%_of_B-lineage_hairy_cell_leukemias_(HCLs),_86%_of_B-lineage_non-Hodgkin's_lymphomas_(NHLs),_and_29%_of_B-lineage_acute_lymphoblastic_leukemias_(ALLs)_were_CD40+._Quantitative_analyses_of_the_correlated_expression_of_CD40_and_other_B-lineage_differentiation_antigens_on_fetal_lymphoid_precursor_cells_by_multiparameter_two-color/three-color_flow_cytometry,_combined_with_analyses_of_sequential_antigen_expression_on_fluorescence-activated_cell_fluorescence_activated_cell_sorter_(FACS)_isolated_immunologically_distinct_fetal_B-cell_precursor_subpopulations_during_in_vitro_proliferation_and_differentiation,_provided_evidence_that_the_acquisition_of_CD40_antigen_in_human_B-cell_ontogeny_occurs_subsequent_to_the_expression_of_CD10_and_CD19_antigens_but_before_the_surface_expression_of_CD20,_CD21,_CD22,_CD24,_and_surface_immunoglobulin_M_(sIgM)._Some_leukemic_pro-B_cells_from_ALL_patients_as_well_as_normal_pro-B_cell_clones_from_fetal_livers_displaying_germline_Ig_heavy_chain_genes_were_CD40+,_indicating_that_the_acquisition_of_CD40_antigen_likely_precedes_the_rearrangement_of_Ig_heavy_chain_genes._CD40+_FACS-sorted_malignant_cells_from_B-lineage_ALL_as_well_as_B-lineage_NHL_patients_were_capable_of_in_vitro_clonogenic_growth,_indicating_the_CD40_antigen_is_expressed_on_clonogenic_leukemia_and_lymphoma_cells._This_hypothesis_was_confirmed_by_the_ability_of_an_anti-CD40_immunotoxin_that_we_used_as_an_antigen-specific_cytotoxic_probe_to_effectively_kill_clonogenic_B-lineage_ALL_and_NHL_cells.